Stay updated on Surufatinib in Biliary Tract Carcinoma: Clinical Trial
Sign up to get notified when there's something new on the Surufatinib in Biliary Tract Carcinoma: Clinical Trial page.

Latest updates to the Surufatinib in Biliary Tract Carcinoma: Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedPage revision updated from v3.6.3 to v3.6.4, signaling a minor platform update. No study data or text across the page appears to have changed.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedThe study record now shows revision v3.6.3, replacing the previous v3.6.2. This indicates a minor editorial update to the page rather than a change to the trial details.SummaryDifference0.1%

- Check38 days agoChange DetectedThe page revision label was updated from v3.6.0 to v3.6.2. This indicates a minor backend or formatting update with no substantive changes to the study details.SummaryDifference0.1%

- Check53 days agoChange DetectedNew help and navigation sections were added, including 'How to Read a Study Record', 'Common Questions', and 'How to Join a Study'. The formatting and display of sponsor information and study-section labels were updated (e.g., 'Intervention/Treatment' vs 'Intervention / Treatment'), and versioning details like 'Revision: v3.6.0' were introduced.SummaryDifference1%

- Check60 days agoChange DetectedThe page's revision label was updated from v3.5.4 to v3.5.5, indicating a small update to the study record display.SummaryDifference0.1%

- Check81 days agoChange DetectedThe page now shows a new revision tag Revision: v3.5.4 in place of the previous Revision: v3.5.3. This indicates a minor update to the study record's documentation on ClinicalTrials.gov.SummaryDifference0.1%

Stay in the know with updates to Surufatinib in Biliary Tract Carcinoma: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Surufatinib in Biliary Tract Carcinoma: Clinical Trial page.